Request Call Back

Contact Us

Duragesic Patch
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

   * Please describe your case:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Duragesic Patch

Duragesic Patch Side Effects Lawsuits | Side Effects: Overdose, Chest Pain, Opiate Withdrawal
CLICK HERE TO DOWNLOAD OUR INFORMATION PACKAGE

Duragesic Patch Side Effects May Link To Overdose Lawsuits

Duragesic | Lawsuits, Lawyers | Side Effects: Overdose, Chest Pain, Opiate Withdrawal

On July 15, 2005 the FDA issued a Public Health Advisory concerning the use of Duragesic Patches (Fentanyl transdermal) in response to reports of deaths in patients using the patch. The FDA is conducting an investigation into the deaths associated with these patches.

Our Dedicated Lawyers and Attorneys Have Years of Experience Handling Defective Drug Lawsuits Such as Duragesic.

The Agency has been examining the circumstances of product use to determine if the reported adverse events may be related to inappropriate use of the patch or factors related to the quality of the product. It is possible that some patients and their health care providers may not be completely aware of the dangers of these potent narcotic drug products and the important recommendations regarding their safe use.

There has been an expanded recall of Duragesic Patches due to possible leaks. Janssen Pharmaceutica, the manufacturer of the Duragesic Patch notified healthcare professionals of an expanded recall of the Duragesic 75 mcg/h, in February 2004. Four additional lots have been subject to the present expanded recall. Some patches from the recalled lots may leak medication due to improper sealing of one of their edges.

If the medication leaks out of the patch, exposure to the medication can result in inadvertent ingestion or increased trans-dermal absorption of the active opiate component fentanyl, leading to potentially life-threatening complications. In addition, leakage of the medication could lead to inadequate dosing, resulting in treatment failure and/or opiate withdrawal.

The Duragesic Patch is indicated for the management of severe, chronic pain (such as cancer pain) that cannot be managed with less powerful drugs such as acetaminophen-opioid combinations and nonsteroidal analgesics.

Moreover, only patients who are already on and tolerant to opioid therapy, and require continuous opioid administration should use the patch. Approved by the U.S. Food and Drug Administration (FDA) in 1990, the Duragesic patch releases fentanyl, a strong opioid, through the skin at a fixed rate for 72 hours. The patch is available only by prescription.

Legal Help For Victims Affected By Duragesic Patch

If you or a loved one used a Duragesic Patch and suffered side effects fill Out The Duragesic Case Review Form, One of Our Lawyers Skilled In Defective Drug Litigation Will Contact You or call us at 1-800-YOURLAWYER (1-800-968-7529).



 

Duragesic PatchRSS Feed

53,000+ Duragesic Pain Patches Recalled by Johnson & Johnson

Jul 19, 2012 | Parker Waichman LLP
Johnson & Johnson has issued a new recall for more than 53,000 Duragesic Pain Patches, according to the company.  The recall was issued because of the discovery of small crystals of fentanyl on at least one patch in the recalled lot. Duragesic and other fentanyl pain patches are used to provide long-lasting relief to cancer patients and others with moderate-to-severe chronic pain.  Fentanyl is a highly-potent opioid painkiller, and has a high potential for abuse and a risk for...

Warning on Transdermal Patches, MRIs

Mar 6, 2009 | Parker Waichman LLP
The U.S. Food and Drug Administration (FDA) has just issued information regarding the use of transdermal patches when undergoing MRI testing.  The medicated patches, which are applied to the skin and that contain aluminum or other metals in the backing of the patches, can contain metal which can overheat during an MRI scan and which can cause skin burns in the immediate area of the patch.The patches are meant to slowly deliver medication transdermally, or through the skin.  But, some...

Misleading Risperdal, Duragesic Patch Claims Prompt Fines in West Virginia Lawsuit

Mar 4, 2009 | Parker Waichman LLP
Risperdal maker Johnson & Johnson has been ordered by a West Virginia judge to pay a hefty fine over a 2003 letter to doctors that obfuscated the antipsychotic drug's diabetes risk. According to Bloomberg News, the same judge also assessed a smaller fine after finding that doctors were misled about the risks and benefits of the company's Duragesic pain patch.Risperdal is one of class of drugs called atypical antipsychotics.  Other atypical antipsychotics include Eli Lilly's Zyprexa,...

Misleading Risperdal, Duragesic Patch Claims Prompt Fines in West Virginia Lawsuit

Mar 4, 2009 | Parker Waichman LLP
Risperdal maker Johnson & Johnson has been ordered by a West Virginia judge to pay a hefty fine over a 2003 letter to doctors that obfuscated the antipsychotic drug's diabetes risk. According to Bloomberg News, the same judge also assessed a smaller fine after finding that doctors were misled about the risks and benefits of the company's Duragesic pain patch.Risperdal is one of class of drugs called atypical antipsychotics.  Other atypical antipsychotics include Eli Lilly's Zyprexa,...

FDA Reviewing Narcotic Painkillers

Feb 10, 2009 | Parker Waichman LLP
The makers of two dozen opioid drugs, including Oxycontin, morphine, methadone and the Duragesic patch, have been ordered by the Food & Drug Administration (FDA) to develop Risk Evaluation and Mitigation Strategy (REMS) plans to reduce the misuse of their painkillers.  The FDA's latest action on these narcotic painkillers comes just days after the agency and the Centers for Disease Control (CDC) announced that they will be working together to look at the rising trend of accidental...

More Duragesic Patch News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo